Cheaper, more effective malaria vaccine wins WHO approval
A highly effective malaria vaccine has been recommended for widespread use by the World Health Organization.
The R21/Matrix-M vaccine, developed by the University of Oxford, is only the second malaria vaccine to be recommended by the WHO. It is the first to meet the WHO’s target of 75% efficacy.
Malaria, a mosquito-borne disease, claims half a million lives every year and mostly affects children under the age of five, and pregnant women … [read more]